SCGB2A2 and skin cancer: However, SCGB2A2 sensitivity is limited particularly for detecting triple-negative breast cancer; moreover, it has been reported to be present in female reproductive tract tumors such as cervix, endometrium, ovary as well as certain salivary gland tumors and skin cancer.